Ma, Z.; Peng, L.; Sheng, Y.; Chu, W.; Fu, Y.
Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals 2024, 17, 378.
https://doi.org/10.3390/ph17030378
AMA Style
Ma Z, Peng L, Sheng Y, Chu W, Fu Y.
Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals. 2024; 17(3):378.
https://doi.org/10.3390/ph17030378
Chicago/Turabian Style
Ma, Zhe, Lin Peng, Yaoyao Sheng, Wenhui Chu, and Yongqian Fu.
2024. "Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways" Pharmaceuticals 17, no. 3: 378.
https://doi.org/10.3390/ph17030378
APA Style
Ma, Z., Peng, L., Sheng, Y., Chu, W., & Fu, Y.
(2024). Anti-Inflammatory Effect of Columbianadin against D-Galactose-Induced Liver Injury In Vivo via the JAK2/STAT3 and JAK2/p38/NF-κB Pathways. Pharmaceuticals, 17(3), 378.
https://doi.org/10.3390/ph17030378